Compile Data Set for Download or QSAR
maximum 50k data
Found 167 of ki data for polymerid = 495
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM312156(6-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butoxy)-2H...)
Affinity DataKi:  0.300nM IC50:  0.980nMAssay Description:Receptor Source: Human recombinant expressed in CHO cells Radioligand: [3H]Spiperone (20-60 Ci/mmol) Control Compound: Haloperidol Incubatio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM312188(6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...)
Affinity DataKi:  0.610nM IC50:  1.96nMAssay Description:Receptor Source: Human recombinant expressed in CHO cells Radioligand: [3H]Spiperone (20-60 Ci/mmol) Control Compound: Haloperidol Incubatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192233(CHEMBL3890178 | US10239870, Example 290)
Affinity DataKi:  39.8nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371858(US10239870, Example 59 | US10239870, Example 60)
Affinity DataKi:  61.7nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192447(CHEMBL3975989 | US10239870, Example 53)
Affinity DataKi:  63.1nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371858(US10239870, Example 59 | US10239870, Example 60)
Affinity DataKi:  66.1nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM372012(US10239870, Example 272)
Affinity DataKi:  95.5nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301962(3-(3-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...)
Affinity DataKi:  110nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301950(3-(4-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...)
Affinity DataKi:  110nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM372001(US10239870, Example 259 | US10239870, Example 260)
Affinity DataKi:  112nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371850(US10239870, Example 49)
Affinity DataKi:  123nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM372001(US10239870, Example 259 | US10239870, Example 260)
Affinity DataKi:  129nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301991(2-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-y...)
Affinity DataKi:  130nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301981(Ethyl 2-(4-(4-(5-fluoro-1H-indol-3-yl)butyl)pipera...)
Affinity DataKi:  130nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371908(US10239870, Example 132)
Affinity DataKi:  135nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301985(2-(4-(4-(5-Fluoro-1H-indol-3-yl)butyl)piperazin-1-...)
Affinity DataKi:  140nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM372016(US10239870, Example 276)
Affinity DataKi:  166nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192316(CHEMBL3985877 | US10239870, Example 57)
Affinity DataKi:  166nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301972(3-(3-(4-(4-Cyanopyrimidin-2-yl)piperazin-1-yl)prop...)
Affinity DataKi:  190nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371889(US10239870, Example 108)
Affinity DataKi:  191nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301956(3-(3-(4-(4,6-Dimethoxypyrimidin-2-yl)piperazin-1-y...)
Affinity DataKi:  200nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192454(CHEMBL3911264 | US10239870, Example 12)
Affinity DataKi:  214nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192445(CHEMBL3959240 | US10239870, Example 285)
Affinity DataKi:  219nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192248(CHEMBL3927895 | US10239870, Example 30)
Affinity DataKi:  224nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301975(2-(4-(3-(5-Fluoro-1H-indol-3-yl)propyl)piperazin-1...)
Affinity DataKi:  230nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192029(CHEMBL3917887 | US10239870, Example 39)
Affinity DataKi:  240nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192239(CHEMBL3922143 | US10239870, Example 48)
Affinity DataKi:  240nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371894(US10239870, Example 118)
Affinity DataKi:  251nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192099(CHEMBL3914556 | US10239870, Example 244)
Affinity DataKi:  251nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192255(CHEMBL3956758 | US10239870, Example 249)
Affinity DataKi:  269nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301982(Ethyl 2-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piper...)
Affinity DataKi:  270nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371953(US10239870, Example 190)
Affinity DataKi:  275nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371911(US10239870, Example 135)
Affinity DataKi:  288nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371969(US10239870, Example 213)
Affinity DataKi:  295nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM372014(US10239870, Example 274)
Affinity DataKi:  302nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301986(2-(4-(3-(5-Fluoro-1H-indol-3-yl)propyl)piperazin-1...)
Affinity DataKi:  310nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM301974(2-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-y...)
Affinity DataKi:  310nMAssay Description:Cell membrane homogenates (24 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]methyl-spiperone in the absence or presence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371998(US10239870, Example 256)
Affinity DataKi:  331nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371904(US10239870, Example 128)
Affinity DataKi:  339nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192318(CHEMBL3979523 | US10239870, Example 284)
Affinity DataKi:  347nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192449(CHEMBL3950540 | US10239870, Example 283)
Affinity DataKi:  347nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371999(US10239870, Example 257)
Affinity DataKi:  347nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192317(CHEMBL3899125 | US10239870, Example 281)
Affinity DataKi:  355nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371933(US10239870, Example 168)
Affinity DataKi:  363nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192243(CHEMBL3978613 | US10239870, Example 234)
Affinity DataKi:  380nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192240(CHEMBL3941818 | US10239870, Example 278)
Affinity DataKi:  389nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192033(CHEMBL3905582 | US10239870, Example 261)
Affinity DataKi:  398nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371975(US10239870, Example 221)
Affinity DataKi:  427nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM50192099(CHEMBL3914556 | US10239870, Example 244)
Affinity DataKi:  427nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM371955(US10239870, Example 192)
Affinity DataKi:  437nMAssay Description:CHO cells stably expressing human dopamine receptor type 2, long variant (hD2L), coupled to Gα16 protein (CHO-Gα16-hD2L) were re-suspended ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 167 total ) | Next | Last >>
Jump to: